We are live on ! Find out more
KCM

Kathmere Capital Management Portfolio holdings

AUM $1.89B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+26.04%
3 Year Est. Return
+62.29%
5 Year Est. Return
+58.06%
10 Year Est. Return
AUM
$944M
AUM Growth
+$69.9M
Cap. Flow
+$72.9M
Cap. Flow %
7.72%
Top 10 Hldgs %
35.47%
Holding
363
New
46
Increased
179
Reduced
83
Closed
24
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVAL icon
51
Alpha Architect International Quantitative Value ETF
IVAL
$221M
$3.2M 0.34%
128,362
+7,732
+6% +$201K
JQUA icon
52
JPMorgan US Quality Factor ETF
JQUA
$8.22B
$3.12M 0.33%
58,913
-712
-1% -$36.9K
WMT icon
53
Walmart Inc
WMT
$887B
$3.04M 0.32%
44,866
+5,769
+15% +$363K
IMOM icon
54
Alpha Architect International Quantitative Momentum ETF
IMOM
$152M
$2.98M 0.32%
107,911
+7,306
+7% +$205K
XOM icon
55
ExxonMobil
XOM
$642B
$2.89M 0.31%
25,087
+604
+2% +$70.3K
SCHX icon
56
Schwab US Large- Cap ETF
SCHX
$71.8B
$2.88M 0.3%
134,379
-3,981
-3% -$82.3K
NVO
57
Novo Nordisk
NVO
$207B
$2.84M 0.3%
19,910
-854
-4% -$113K
BUFB icon
58
Innovator Laddered Allocation Buffer ETF
BUFB
$320M
$2.82M 0.3%
92,259
+136
+0.1% +$4.04K
SCHE icon
59
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$2.73M 0.29%
102,768
-1,944
-2% -$50.7K
V icon
60
Visa
V
$684B
$2.71M 0.29%
10,337
+719
+7% +$197K
HD icon
61
Home Depot
HD
$331B
$2.64M 0.28%
7,675
+1,188
+18% +$405K
MRK icon
62
Merck
MRK
$322B
$2.55M 0.27%
20,607
+1,062
+5% +$137K
PXH icon
63
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.94B
$2.54M 0.27%
125,307
-1,494
-1% -$30.2K
PG icon
64
Procter & Gamble
PG
$335B
$2.52M 0.27%
15,287
+1,967
+15% +$322K
UNH icon
65
UnitedHealth
UNH
$380B
$2.43M 0.26%
4,768
+958
+25% +$470K
VZ icon
66
Verizon
VZ
$195B
$2.35M 0.25%
56,887
+2,393
+4% +$96.4K
JNJ icon
67
Johnson & Johnson
JNJ
$622B
$2.23M 0.24%
15,284
-33
-0.2% -$4.91K
AMZN icon
68
Amazon
AMZN
$2.92T
$2.2M 0.23%
11,404
+2,628
+30% +$483K
BRK.B icon
69
Berkshire Hathaway Class B
BRK.B
$1.11T
$2.17M 0.23%
5,329
+1,453
+37% +$594K
USHY icon
70
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.3B
$2.13M 0.23%
58,761
+29,293
+99% +$1.06M
GSIE icon
71
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.01B
$2.08M 0.22%
61,779
-843
-1% -$28.7K
PTLC icon
72
Pacer Trendpilot US Large Cap ETF
PTLC
$3.26B
$2M 0.21%
40,280
+68
+0.2% +$3.25K
HON icon
73
Honeywell
HON
$77.7B
$1.82M 0.19%
9,035
+1,102
+14% +$210K
RELX icon
74
RELX
RELX
$61.9B
$1.79M 0.19%
39,063
-541
-1% -$23.5K
ORCL icon
75
Oracle
ORCL
$371B
$1.71M 0.18%
12,146
+1,240
+11% +$154K

Similar funds

Kathmere Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Kathmere Capital Management held 363 positions worth $944M, up 8% from $874M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kathmere Capital Management deployed $72.9M of net new capital in Q2 2024, opening 46 new positions and adding to 179 existing holdings. Its largest new stake was Distillate Small/Mid Cash Flow ETF: 313,512 shares worth $10.9M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Schwab Fundamental US Small Company Index ETF, an estimated $9.57M trimmed.

  • Kathmere Capital Management's largest Q2 2024 buy was Distillate Small/Mid Cash Flow ETF: 313,512 shares worth $10.9M.
  • Kathmere Capital Management added most to iShares iBonds Dec 2024 Term Corporate ETF in Q2 2024, an estimated $4.5M increase.
  • Kathmere Capital Management's biggest Q2 2024 reduction was Schwab Fundamental US Small Company Index ETF, cutting an estimated $9.57M.
  • Kathmere Capital Management fully exited Schwab US Dividend Equity ETF in Q2 2024, selling an estimated $415K.
  • Kathmere Capital Management's ten largest holdings make up 35% of its $944M portfolio in Q2 2024.
  • Kathmere Capital Management opened 46 new positions and closed 24 in Q2 2024.
  • Kathmere Capital Management's portfolio value rose 8% quarter-over-quarter to $944M.

Based on Kathmere Capital Management's 13F filing for Q2 2024, filed 1 Jul 2024.